Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-09-062971
Filing Date
2009-03-25
Accepted
2009-03-25 15:38:51
Documents
7
Period of Report
2008-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 580446
2 FORM OF STOCK OPTION AWARD UNDER 2008 STOCK OPTION PLAN dex104.htm EX-10.4 7302
3 SECOND AMENDMENT TO THE SUPPLY AND LICENSE AGREEMENT dex1021.htm EX-10.21 8390
4 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM dex231.htm EX-23.1 1334
5 CERTIFICATION OF CEO PURSUANT TO EXCHANGE ACT RULES 13A-14(A)/15D-14(A) dex311.htm EX-31.1 9375
6 CERTIFICATION OF DIRECTOR OF FINANCE PURSUANT TO ACT RULES 13A-14(A)/15D-14(A) dex312.htm EX-31.2 9307
7 CERTIFICATION OF THE CEO AND DIRECTOR OF FINANCE PURSUANT TO SECTION 1350 dex321.htm EX-32.1 3510
  Complete submission text file 0001193125-09-062971.txt   621052
Mailing Address 1199 MADIA STREET PASADENA CA 91103
Business Address 1199 MADIA STREET PASADENA CA 91103 6267921235
AUTOIMMUNE INC (Filer) CIK: 0000879106 (see all company filings)

EIN.: 133489062 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-20948 | Film No.: 09703980
SIC: 2836 Biological Products, (No Diagnostic Substances)